HOXD9 and hepatocellular carcinoma: Clinically, elevated levels of HOXD9 have been detected in various cancers, such as glioblastomas [8], cervical cancer [9], colorectal carcinoma [10], gastric cancer [11], hepatocellular carcinoma [12], and esophageal squamous cell carcinomas [13].